WEBSITE CURRENTLY UNDER CONSTRUCTION.
Thank you for visiting the DigitalVision Systems website. Our website is currently being significantly revised. It should be completed soon so please check back. In the meantime, if you have questions, please feel free to contact us.

DigitalVision, LLC, dba DigitalVision Systems (“DVS”) is an Atlanta-based private company developing the VisionOptimizer™ System that will provide the vision care consumer with a novel ability to preview, compare, and select the best available product and/or to interactively-optimize a product for the patient’s individual visual needs. The VisionOptimizer can create proprietary designs for spectacles, contact lenses, refractive, and implant procedures—including presbyopia-correcting IOLs. Patients can experience the improved vision that DVS's new products provide compared to error-prone phoropter-based products while viewing real-world scenes in the VisionOptimizer’s viewport, bringing an all-new and engaging experience to vision care consumers.

The VisionOpimizer’s high-resolution displays and wavefront generator can be controlled by a technician, a doctor—or interactively—by the patient. A smaller device, remotely-controlled through the Internet, can deliver vision testing and product sales to most any location through a small-footprint “VisionCube™”. The Company has secured four issued patents to protect its technology and it is expanding its IP portfolio with ten additional patents-pending.

DVS was founded by Keith P. Thompson, MD, a well-known refractive surgeon, and entrepreneur/inventor with specific expertise in physiological optics. DigitalVision has been selected as a VentureLab company, a Georgia Tech program that provides financial support to start-ups deemed to have strong commercial potential. DVS is developing the VisionOptimizer in collaboration with Georgia Tech Research Institute’s (GTRI) Electro-Optical Systems Lab (EOSL), a leader in developing advanced optical technologies for the Department of Defense and Industry. The VisionOptimizer prototype is presently under construction at EOSL, and clinical trials at Georgia Tech will commence in mid-2012. The Company will derive revenues from sales of VisionOptimizer Systems and from recurring sales of its licensed corrective products.